US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.8700
- -0.1300-13.00%
Close Sep 12 16:00 ET
- 0.8254
- -0.0446-5.13%
Pre 05:27 ET
3.89MMarket Cap-600P/E (TTM)
1.0600High0.7310Low11.08MVolume1.0500Open1.0000Pre Close14.43MTurnover340.04%Turnover RatioLossP/E (Static)4.47MShares1.980052wk High4.92P/B2.84MFloat Cap0.500052wk Low--Dividend TTM3.26MShs Float19.5600Historical High--Div YieldTTM32.90%Amplitude0.5000Historical Low1.3020Avg Price1Lot Size
Protagenic Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -84.70%924.6K | -68.32%2.42M | -49.16%4.06M | -49.16%4.06M | -35.33%5.27M | -31.86%6.04M | -21.82%7.65M | -23.07%7.98M | -23.07%7.98M | -24.89%8.15M |
| -Cash and cash equivalents | 321.35%924.6K | 500.60%831.78K | 498.49%1.29M | 498.49%1.29M | -3.15%153.33K | -35.21%219.44K | -71.28%138.49K | -60.24%215.19K | -60.24%215.19K | -65.59%158.32K |
| -Short-term investments | --0 | -78.81%1.59M | -64.34%2.77M | -64.34%2.77M | -35.96%5.12M | -31.73%5.82M | -19.25%7.51M | -21.02%7.76M | -21.02%7.76M | -23.09%7.99M |
| Prepaid assets | -49.20%444.29K | 213.82%43.99K | 152.95%144.03K | 152.95%144.03K | 2.45%104.08K | 498.16%874.67K | 8.53%14.02K | -91.73%56.94K | -91.73%56.94K | -87.34%101.58K |
| Total current assets | -80.21%1.37M | -67.80%2.47M | -47.73%4.2M | -47.73%4.2M | -34.86%5.38M | -23.26%6.92M | -21.78%7.66M | -27.34%8.04M | -27.34%8.04M | -29.19%8.25M |
| Non current assets | ||||||||||
| Net PPE | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K | ---- |
| Total non current assets | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K | --1.78K | --1.78K | --0 |
| Total assets | -78.80%1.47M | -66.36%2.58M | -46.21%4.32M | -46.21%4.32M | -34.18%5.43M | -23.24%6.92M | -21.76%7.67M | -27.33%8.04M | -27.33%8.04M | -29.19%8.25M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | -44.26%155.49K | -44.26%155.49K | -49.08%139.34K |
| -accounts payable | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K | -44.26%155.49K | -44.26%155.49K | -49.08%139.34K |
| Current accrued expenses | -39.02%581.1K | -52.38%337.15K | -12.69%541.45K | -12.69%541.45K | 48.94%616.82K | 639.89%952.91K | 40.37%707.97K | 19.13%620.15K | 19.13%620.15K | -8.13%414.14K |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K | ---- |
| -Current debt | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K | --344.23K | --344.23K | ---- |
| Current liabilities | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 131.28%1.28M | 225.08%1.51M | 59.76%1.25M | 40.06%1.12M | 40.06%1.12M | -23.60%553.48K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.29%318.78K |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.29%318.78K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -43.29%318.78K |
| Total liabilities | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 46.76%1.28M | 99.02%1.51M | 16.06%1.25M | 0.17%1.12M | 0.17%1.12M | -32.20%872.26K |
| Shareholders'equity | ||||||||||
| Share capital | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 | 1.89%1.73K |
| -common stock | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 | 0.46%434 | 0.46%434 | 1.89%1.73K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -23.11%-34.11M | -22.67%-32.5M | -19.40%-30.78M | -19.40%-30.78M | -15.59%-29.1M | -14.24%-27.71M | -12.35%-26.5M | -16.00%-25.78M | -16.00%-25.78M | -18.02%-25.18M |
| Paid-in capital | 3.93%35.03M | 3.53%34.72M | 3.56%34.56M | 3.56%34.56M | 2.11%33.87M | 2.27%33.7M | 2.56%33.54M | 2.96%33.37M | 2.96%33.37M | 4.07%33.17M |
| Gains losses not affecting retained earnings | 77.81%-130.16K | 86.20%-86.77K | 83.23%-113.55K | 83.23%-113.55K | -0.43%-617.74K | -30.42%-586.46K | -57.44%-628.76K | -172.56%-676.91K | -172.56%-676.91K | -256.84%-615.11K |
| Total stockholders'equity | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M | -28.82%7.38M |
| Total equity | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M | -30.42%6.92M | -30.42%6.92M | -28.82%7.38M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data